908 Devices (NASDAQ:MASS) Given Sell (E+) Rating at Weiss Ratings

908 Devices (NASDAQ:MASS)‘s stock had its “sell (e+)” rating reiterated by equities researchers at Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.

MASS has been the subject of several other reports. Stifel Nicolaus reduced their target price on 908 Devices from $17.00 to $6.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Leerink Partnrs downgraded 908 Devices from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 13th. Leerink Partners reissued a “market perform” rating and issued a $4.00 target price (down from $12.00) on shares of 908 Devices in a report on Wednesday, November 13th. Finally, Stephens reaffirmed an “overweight” rating and set a $6.00 price objective on shares of 908 Devices in a research note on Wednesday, January 15th. Two analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $5.33.

908 Devices Stock Performance

908 Devices stock opened at $2.66 on Wednesday. 908 Devices has a fifty-two week low of $1.81 and a fifty-two week high of $7.91. The company has a market capitalization of $92.62 million, a P/E ratio of -1.50 and a beta of 0.99. The stock has a 50-day simple moving average of $2.37 and a 200-day simple moving average of $3.06.

Institutional Trading of 908 Devices

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. 49 Wealth Management LLC raised its stake in 908 Devices by 16.2% during the 3rd quarter. 49 Wealth Management LLC now owns 31,099 shares of the company’s stock valued at $108,000 after acquiring an additional 4,343 shares during the last quarter. Hsbc Holdings PLC increased its position in 908 Devices by 32.2% during the 4th quarter. Hsbc Holdings PLC now owns 21,007 shares of the company’s stock worth $46,000 after purchasing an additional 5,112 shares during the period. State Street Corp increased its position in 908 Devices by 1.2% during the 3rd quarter. State Street Corp now owns 479,044 shares of the company’s stock worth $1,662,000 after purchasing an additional 5,704 shares during the period. Geode Capital Management LLC increased its position in 908 Devices by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 567,788 shares of the company’s stock worth $1,970,000 after purchasing an additional 6,634 shares during the period. Finally, LPL Financial LLC increased its position in 908 Devices by 13.0% during the 4th quarter. LPL Financial LLC now owns 63,287 shares of the company’s stock worth $139,000 after purchasing an additional 7,295 shares during the period. 88.06% of the stock is owned by hedge funds and other institutional investors.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.